Status:
TERMINATED
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-center, longitudinal observational study of adult human immunodeficiency virus (HIV) participants at academic and community-based practices in the United States who are switching from ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of HIV
- Switching antiretroviral regimen(s) for the first time at the start of the study
Exclusion
- Currently pregnant
- Presence of active tuberculosis, Hepatitis B, and/or Hepatitis C and receiving treatment for the condition(s) during the study period
- Presence of active pneumonia or other signs of opportunistic infections at the start of the study
- Currently participating in a clinical trial
Key Trial Info
Start Date :
November 9 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2013
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01814722
Start Date
November 9 2012
End Date
October 31 2013
Last Update
April 21 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.